Knowledge of 18-19 Years Old About Papillomavirus and HPV Vaccination
CO-HPV
1 other identifier
observational
29
1 country
1
Brief Summary
Today, cancers associated with papillomavirus infection affect 6,300 new people each year in France, men and women combined. The papillomavirus vaccine is currently the only vaccine that protects against HPV-associated cancers. However, in its report on vaccination coverage for 2024, Santé Publique France reveals that 41.5% and 37.4% of the 18- and 19-year-old French population respectively have a complete vaccination schedule. Information, education and communication about HPV are essential to enable the entire population to make informed and responsible decisions about HPV. Increasing information and immunization coverage for papillomavirus is part of the government's ambitious health plans with the national sexual health strategy and college vaccination campaign.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2025
CompletedFirst Submitted
Initial submission to the registry
February 6, 2026
CompletedFirst Posted
Study publicly available on registry
February 18, 2026
CompletedFebruary 18, 2026
February 1, 2026
2 months
February 6, 2026
February 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Knowledge about HPV and anti-HPV vaccination
Knowledge about HPV and anti-HPV vaccination will be assessed by a questionnaire developed by a team of midwives and methodologists. Questions will address: Knowledge about HPV infection Knowledge of prevention measures Knowledge about HPV vaccination
Day 0
Interventions
Data collection
Eligibility Criteria
girls and boys aged 18 to 19 years old
You may qualify if:
- Boys and girls 18 to 19 years of age Vaccinated or not against HPV Sexually active or not Agreeing to take part in the study
You may not qualify if:
- Minors Age 20 and over Protected by law (guardianship, curatorship, safeguard of justice) Not wishing to answer the questionnaire
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ufr Medecine Urca
Reims, 51100, France
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 6, 2026
First Posted
February 18, 2026
Study Start
December 1, 2024
Primary Completion
February 1, 2025
Study Completion
July 1, 2025
Last Updated
February 18, 2026
Record last verified: 2026-02